A company in which technology specialist VCT manager Quester has invested stands to receive a boost from rising fears over a possible Avian flu outbreak. The investment group backed PowderMed via the Isis College Fund it manages, in an initial £20 million fundraising in May 2004.
Specialist healthcare investor Sitka, founded by former Schroders venture capitalist Gerard Tardy and Dr Louis Nisbet, who built up quoted biotech Xenova, has been bought by Noble Fund Managers.
Diabetes testing technology developer Quotient Diagnostics has raised £800,000 from a syndicate of backers - including The Capital Fund, GEIF Ventures and NESTA - and will use the cash to develop its technologies through to commercialisation.
Private investor network Hotbed has raised £4 million from its members, as part of a total £15 million expansion capital package for nursing homes operator Mimosa Healthcare.
A producer of equipment using lasers that treat medical and cosmetic skin conditions will join AIM next week, having raised £1.6 million net via a placing organised by Corporate Synergy.
Armstrong Healthcare, the developer of precision robots for neurosurgical, cardio-thoracic and laparoscopic procedures, has completed a £1 million top-up fundraising to support clinical trials of its three main products.
Legal & General Ventures, the private equity arm of the eponymous financial services group, has bought healthcare products manufacturer and distributor Verna for £60 million.
Plethora Solutions, developer of products treating a variety of urological diseases, has floated on AIM, raising £10 million in a placing advised by Collins Stewart.
Rolf Stahel, the well-regarded former chief executive of Shire Pharmaceuticals, has agreed to become non-executive chairman of Oxford-based PowderMed, a specialist in developing immunotherapeutics.
